Skip to content

Supplier News

Amneal gets U.S. FDA approval for calcium gluconate injection

Amneal gets U.S. FDA approval for calcium gluconate injection

Amneal Pharmaceuticals has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA”) for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL. This injectable product is currently on the U.S. FDA shortage product list.